About The Cranemere Group
The Cranemere Group is a holding company structured to provide permanent capital to mid-market businesses, including healthcare service and industrial companies. Unlike traditional private equity, Cranemere does not operate on a fixed fund life and does not pursue forced exits on a timeline. The firm’s healthcare exposure is in care delivery and tech-enabled services. AI is not a stated focus, and Cranemere’s model is oriented toward long-term ownership rather than transformation through software.
Check sizes are $25M and above, with deployment concentrated in the United States and selectively in Europe. Specific portfolio companies in the healthcare AI segment are not provided in the source data.
For healthcare AI founders, Cranemere is relevant only for owners of profitable, durable services businesses who specifically want a permanent-capital partner rather than a traditional PE exit cycle. Early-stage software AI founders are not a fit. The right approach is for founders looking for a long-term home for an established business.
Founder reviews
Other portfolio companies
Companies in The Cranemere Group's portfolio not currently in our directory.
Team
Pitch / review this investor
Have you raised from The Cranemere Group? Founders only — share your honest experience (anonymous OK, moderated before publishing).